Johnson & Johnson Q2 FY26: where the revenue came from and where it went
The whole income statement of Johnson & Johnson for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Mar 30 – Jun 28, 2026
- Reported
- Jul 23, 2026
Revenue$25.3B
+7% year over year
Gross profit$17.3B
68% margin
Operating profit$7.2B
28% margin
Net profit$5.5B
22% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 25.3 | 100% | +7% |
| Innovative medicine | 16.4 | 65% | +8% |
| Med tech | 8.9 | 35% | +5% |
| Cost of revenue | −8.1 | 32% | |
| Gross profit | 17.3 | 68% margin | +0pp |
| SG&A | −6.4 | 25% | +1pp |
| Other | −3.7 | 15% | +0pp |
| Operating profit | 7.2 | 28% margin | +0pp |
| Interest & other costs | −0.4 | ||
| Tax | −1.2 | ||
| Net profit | 5.5 | 22% margin | −1pp |
304 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest